Short answer
Magnesium glycinate draws 40,500 searches a month in Poland against 1,000,000 in the US. Adjusted for population, Poles search for it at 0.37 of the US rate, while generic magnesium sits at 0.82. In EU law the form is listed as "magnesium bisglycinate" in Annex II to Directive 2002/46/EC, so it may be used in food supplements. The Polish GIS supplement team gives 400 mg as the maximum magnesium level in a supplement, EFSA's tolerable upper level for supplemental magnesium is 250 mg a day, and ten authorised EU health claims apply to magnesium regardless of form.
Magnesium glycinate demand in Poland vs the US
Search data: Google Ads Keyword Planner, average monthly searches, October 2025 - September 2026. The Polish figure is the Polish name searched from Poland, the US figure the English name searched from the US. Per-million figures use the population of Poland at the end of 2025 (GUS, Poland in Figures 2026, 37.333 million) and of the US on 1 July 2025 (US Census Bureau, Vintage 2025, 341.8 million).
| Term | US searches | PL searches | US per million | PL per million | Index PL/US |
|---|---|---|---|---|---|
| Magnesium glycinate | 1,000,000 | 40,500 | 2,925.7 | 1,084.8 | 0.37 |
| Magnesium | 450,000 | 40,500 | 1,316.6 | 1,084.8 | 0.82 |
Two readings follow. First, 40,500 searches a month makes magnesium glycinate a real market in Poland already, larger than many whole ingredient categories. Second, the gap is in the form, not the mineral. Poles search for magnesium at 0.82 of the US rate per head. They search for the glycinate form at 0.37. The shopper already buys magnesium; fewer of them have learned to ask for this form by name.
Search is not sales. These figures show interest, not volume sold or price level. For what is growing inside Poland over time, see our analysis of the fastest-growing supplement ingredients in Poland.
Magnesium bisglycinate in EU law: is the form allowed?
Yes. In the EU only listed forms of vitamins and minerals may go into a food supplement. Directive 2002/46/EC, Article 4(1) states: "Only vitamins and minerals listed in Annex I, in the forms listed in Annex II, may be used for the manufacture of food supplements".
Magnesium is in Annex I. Annex II, as replaced by Commission Regulation (EC) No 1170/2009. The 2009 text lists 21 magnesium compounds, among them "magnesium bisglycinate", alongside the citrate salts, malate, taurate, oxide, chloride and others. The same regulation replaced both annexes of the Directive in one step. In Poland, the list of minerals is repeated in Annex 1 to the Minister of Health regulation on the composition and labelling of food supplements, whose consolidated text was published in October 2026 (Dz.U. 2026 poz. 1364), where magnesium appears as "Magnez (mg)".
Two practical points for a US brand. The legal name is "magnesium bisglycinate", not "magnesium glycinate". Use the Annex II name in the ingredient list on the Polish label and in the GIS notification file, and keep "glycinate" for marketing copy if you want the search term. Second, check every other magnesium form in a blend the same way. Annex II has been amended since 2009, for example by Commission Regulation (EU) 2025/2225, which deals with magnesium L-threonate, so read the current consolidated version before you sign off a formula.
Magnesium supplements in Poland: the dose GIS expects
EU law has not set harmonised maximum amounts of minerals in food supplements. In Poland, the advisory supplement team of the Chief Sanitary Inspector publishes recommended maximum levels. Its table of maximum mineral levels gives magnesium at 400 mg, under resolution 19/2019, with no recommended warning. The page describes these resolutions as opinions of an advisory body; it does not call them binding. Treat 400 mg as the working ceiling for a Polish notification.
EFSA has set a lower reference point. In its opinion on trimagnesium dicitrate, EFSA refers to "the tolerable upper level (UL) of 250 mg/day for supplemental magnesium".
At the low end, the Polish regulation (Dz.U. 2026 poz. 1364, § 4) requires the vitamin and mineral content per recommended daily portion to take account of upper safe levels, and sets a minimum of 15% of the reference intake values.
| Reference point | Magnesium level | Source | Legal nature |
|---|---|---|---|
| GIS supplement team, recommended maximum | 400 mg | GIS, resolution 19/2019 | Advisory opinion |
| EFSA tolerable upper level, supplemental magnesium | 250 mg/day | EFSA Journal opinion | Scientific reference |
| Polish minimum per daily portion | 15% of the reference intake | Dz.U. 2026 poz. 1364, § 4(2) | Binding regulation |
Our advice: compare your US daily serving, in elemental magnesium, with both figures. If it exceeds the GIS level, reduce the serving for Poland rather than argue the case. For how GIS treats doses for other ingredients, see our page on novel food and maximum doses in Poland.
What you can say about magnesium glycinate on a Polish label
Health claims in the EU attach to the nutrient, not to the form. Regulation (EU) No 432/2012 authorises ten claims for magnesium, and they apply to bisglycinate in the same way as to citrate or oxide:
- "Magnesium contributes to a reduction of tiredness and fatigue"
- "Magnesium contributes to electrolyte balance"
- "Magnesium contributes to normal energy-yielding metabolism"
- "Magnesium contributes to normal functioning of the nervous system"
- "Magnesium contributes to normal muscle function"
- "Magnesium contributes to normal protein synthesis"
- "Magnesium contributes to normal psychological function"
- "Magnesium contributes to the maintenance of normal bones"
- "Magnesium contributes to the maintenance of normal teeth"
- "Magnesium has a role in the process of cell division"
Each claim may be used only for food that is at least a source of magnesium, as defined for the "source of" nutrition claim in the Annex to Regulation (EC) No 1924/2006: at least a significant amount of the mineral.
Three things US copy often does that does not work in Poland. None of the ten claims mentions sleep, so "for better sleep" is not an authorised claim. "Highly absorbable" or "gentle on the stomach" are comparative or functional statements about the form that no authorised claim covers. And the Polish label uses the claim in Polish, worded as authorised. Our guide to health claims for supplements in Poland explains how much rewording GIS tolerates.
Formats for magnesium glycinate in Poland
Chelated forms such as bisglycinate carry less elemental magnesium per gram than oxide, so the same dose needs more raw material. That shapes the format:
- Capsules. The familiar format for glycinate. Expect two or more capsules per daily serving to reach a meaningful dose. Check the capsule size against what Polish shoppers are used to swallowing.
- Tablets. More material per unit, but larger tablets. Ask your manufacturer what tablet size the formula needs before you design the pack.
- Powder and sachets. Fits higher doses and evening-drink positioning. The taste of the raw material and the sweetener choice decide whether it works.
- Combinations. If you pair magnesium with vitamin B6 or another nutrient, every addition brings its own Annex II form, maximum level and claims to check.
Worked example: hitting a target dose
Illustrative figures only. Use the elemental magnesium content from your raw material specification, not a figure from the internet.
| Step | Illustrative value |
|---|---|
| Target elemental magnesium per daily serving | 200 mg |
| Elemental magnesium in the raw material (from supplier spec, assumed) | 20% |
| Raw material needed per serving | 200 / 0.20 = 1,000 mg |
| Capsules per serving at 500 mg fill | 2 |
| Check against GIS level of 400 mg | Pass |
| Check against EFSA UL of 250 mg/day | Pass |
| Check against 15% minimum of reference intake | Calculate with the reference intake for magnesium |
Declare the amount of elemental magnesium per daily portion on the label, not the weight of the bisglycinate compound. A label that says "1,000 mg magnesium bisglycinate" without the elemental figure invites questions and confuses shoppers comparing products.
What to launch: a magnesium glycinate plan for Poland
- Lead with the form, not the mineral. Shoppers already buy magnesium. Position the product around what bisglycinate is, using only authorised claims for magnesium.
- Set the serving under 400 mg elemental magnesium. And decide consciously whether you also stay under EFSA's 250 mg. Write the reasoning into your notification file.
- Use the Annex II name. "Magnesium bisglycinate" in the ingredient list and notification. "Glycinate" can appear in marketing copy.
- Translate claims, do not invent them. Pick two or three of the ten authorised claims and use them in Polish as worded.
- Prepare the label and notification together. The GIS notification needs the Polish label text, so finish the label first.
- Price against the magnesium shelf. The comparison is with every magnesium product, not only glycinate. Show the cost per daily dose of elemental magnesium in your own planning.
- Track the search gap. Re-pull the same terms after 12 months. If the index for glycinate rises toward the generic magnesium level, the form is becoming mainstream and competition will follow.
Sources
Primary legal texts and official pages used in this guide. Always read the consolidated version in force on the day you act.
- Directive 2002/46/EC on food supplements, Article 4(1) - EUR-Lex
- Commission Regulation (EC) No 1170/2009 replacing Annexes I and II to Directive 2002/46/EC - EUR-Lex
- Commission Regulation (EU) No 432/2012, list of permitted health claims (magnesium) - EUR-Lex
- Commission Regulation (EU) 2025/2225 amending Annex II to Directive 2002/46/EC (magnesium L-threonate) - EUR-Lex
- Regulation (EC) No 1924/2006 on nutrition and health claims, Annex ("source of" vitamins and minerals) - EUR-Lex
- GIS - Zespół do spraw Suplementów Diety, Tabela 3: maximum mineral levels (magnesium, resolution 19/2019)
- Minister of Health regulation on the composition and labelling of food supplements, consolidated text, Dz.U. 2026 poz. 1364
- EFSA Journal - opinion on trimagnesium dicitrate anhydrous (UL for supplemental magnesium)
- Statistics Poland (GUS), Poland in Figures 2026 - population at 31 December 2025
- US Census Bureau, Vintage 2025 - US resident population at 1 July 2025